FDA D.I.S.C.O. Burst Edition: FDA approval of Brukinsa (zanubrutinib) for adult patients with Waldenström’s macroglobulinemia
0:00
3:00
Listen to a soundcast of the August 31, 2021 FDA approval of Brukinsa (zanubrutinib) for adult patients with Waldenström’s macroglobulinemia
Mais episódios de "FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)"
Não percas um episódio de “FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)” e subscrevê-lo na aplicação GetPodcast.